SYMTOMAX’S PARTNER GREATER CANNABIS CEO INTERVIEWED ON YAHOO FINANCE

Symtomax’s partner the Greater Cannabis Company CEO was interviewed on Yahoo Finance today. With growing concern over vaping-related illnesses and the increase in the hundreds of patients experiencing lung ailments, Symtomax’s partnership , gives them exclusive rights to use their tested patented delivery products & distribution throughout Europe, Middle East and Africa, offering a safe […]

Continue reading
gcanrx symtomax

GREATER CANNABIS COMPANY PARTNERS WITH SYMTOMAX® TO EXPAND ACROSS ACROSS EUROPE, THE MIDDLE EAST AND AFRICA

BALTIMORE, MD – May 7, 2019 — Greater Cannabis Company (OTC: GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, today announced it has entered into a letter of agreement (LOI) with European-based Symtomax, a licensed group on medical cannabis cultivation, research and distribution with over 40 years of […]

Continue reading